Getting there? Salvage therapy for refractory Langerhans cell histiocytosis in children
- 30 November 2005
- journal article
- editorial
- Published by Elsevier in European Journal Of Cancer
- Vol. 41 (17) , 2592-2594
- https://doi.org/10.1016/j.ejca.2005.07.008
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- A New clinical score for disease activity in Langerhans cell histiocytosisPediatric Blood & Cancer, 2004
- Diabetes Insipidus and Langerhans Cell Histiocytosis: A Case Report of Reversibility With 2-ChlorodeoxyadenosineJournal of Pediatric Hematology/Oncology, 2003
- Response to initial treatment of multisystem langerhans cell histiocytosis: An important prognostic indicatorMedical and Pediatric Oncology, 2002
- A randomized trial of treatment for multisystem Langerhans’ cell histiocytosisThe Journal of Pediatrics, 2001
- LANGERHANS CELL HISTIOCYTOSIS: Central Nervous System Involvement Treated Successfully with 2-ChlorodeoxyadenosinePediatric Hematology and Oncology, 2001
- Cyclosporine A therapy for multisystem Langerhans cell histiocytosisMedical and Pediatric Oncology, 1999
- A multicentre retrospective survey of Langerhans' cell histiocytosis: 348 cases observed between 1983 and 1993. The French Langerhans' Cell Histiocytosis Study Group.Archives of Disease in Childhood, 1996
- 2-Chlorodeoxyadenosine-Induced Complete Remissions in Langerhans-Cell HistiocytosisAnnals of Internal Medicine, 1994
- LCH‐I: A randomized trial of etoposide vs. vinblastine in disseminated langerhans cell histiocytosisMedical and Pediatric Oncology, 1994
- Cytosine‐arabinoside, vincristine, and prednisolone in the treatment of children with disseminated langerhans cell histiocytosis with organ dysfunction: Experience at a single institutionMedical and Pediatric Oncology, 1993